MDLZ
Mondelez International, Inc.
Updated 2026-05-07
Mondelez International, Inc. (MDLZ) Stock Price, Analysis & Forecast 2026
$61.55 ▲ 0.39%
MDLZ interactive stock chart
Key statistics
7.0/10
6.3/10
10/10
6.5/10
7.6/10
| Market cap | $78.74B | Today’s volume | 347,558.33875 |
| Revenue (TTM) | $38.54B | Avg. daily volume | N/A |
| P/E ratio | 30.25x | Today’s range | 61.219 – 61.71 |
| Debt / equity | 0.84x | 52-week range | 51.2-71.15 |
| Net margin | 6.65% | Beta | 0.404x |
| ROE | N/A% | Current ratio | 0.54x |
| Dividend & yield | $1.97 (0.03%) | Next earnings | 2026-07-28 |
| FCF yield | 3.27% | FMP rating | B |
| DCF fair value | $131.05 (113.7%) | Revenue growth | 5.8% |
See also: CCEP · CL · DEO · HSY · K · All Food Confectioners stocks
Is MDLZ a good stock to buy in 2026?
A significant majority of analysts (75.6%) rate MDLZ stock a “Buy,” with a consensus target offering a +9.2% upside. However, MDLZ valuation appears elevated with a P/E ratio of 30.25x, substantially higher than the sector average of 20x. Despite the high P/E, our discounted cash flow (DCF) model suggests MDLZ is significantly undervalued at $131.05, representing a potential upside of 113.7% from its current price.
Top Weakness: High P/E
Overall: Cautious Buy
2026 MDLZ price scenarios
Based on analyst consensus of $67 from 41 analysts. Not a prediction by Alert Invest.
Key risks:
- Intensified competition in the global snack market, eroding market share.
- Significant increase in commodity prices (e.g., cocoa, sugar) impacting gross margins.
- Negative consumer trends away from packaged snacks due to health concerns or evolving tastes.
Assumes:
- Mondelez International (MDLZ) maintains its steady revenue growth, with analysts forecasting approximately $44.73 billion for the forward period.
- Forward EPS aligns with the current estimate of $4.25721, indicating consistent operational performance.
- The company continues its strategic acquisitions and brand investments to sustain its competitive position in the Food Confectioners industry.
Requires:
- Successful product innovation and expansion into high-growth emerging markets, exceeding revenue forecasts.
- Strong pricing power and effective cost management initiatives lead to significant margin expansion (above 6.65% net margin).
- Global economic stability boosts consumer spending on discretionary snack items, driving higher sales volumes for MDLZ stock.
How does MDLZ compare?
Side-by-side valuation, growth, and analyst ratings vs top Consumer Defensive competitors.
About Mondelez International, Inc. (MDLZ)
Mondelez International, Inc., through its subsidiaries, manufactures, markets, and sells snack food and beverage products in the Latin America, North America, Asia, the Middle East, Africa, and Europe. It provides biscuits, including cookies, crackers, and salted snacks; chocolates; and gums and candies, as well as various cheese and grocery, and powdered beverage products. The company’s snack brand portfolio includes Cadbury, Milka, and Toblerone chocolates; Oreo, belVita, and LU biscuits; Halls candies; Trident gums; and Tang powdered beverages.
Mondelez International, Inc. is led by CEO Dirk Van de Put and employs approximately 90,000 individuals globally, a testament to its vast operational scale. The company’s distinctive strengths lie in its diversified brand portfolio of iconic snacks, including global powerhouses like Oreo and Cadbury, offering significant brand recognition and consumer loyalty across various markets. Its expansive global distribution network further cements its position as a leading player in the Food Confectioners industry.
MDLZ competitive moat and business analysis
Mondelez International (MDLZ) maintains a competitive advantage through its robust portfolio of globally recognized brands, allowing it to command significant market share in the Food Confectioners industry. Despite a net margin of 6.65%, which is competitive within the consumer defensive sector, the company benefits from strong brand equity and consumer loyalty. While specific Return on Equity (ROE) and Return on Invested Capital (ROIC) figures are not available, the stable nature of its core business and consistent demand for its snack products suggest a durable economic moat. This brand power enables pricing flexibility and resilience during economic downturns, a key characteristic of a strong consumer defensive stock.
Mondelez’s revenue streams are globally diversified, stemming from various product categories including biscuits, chocolate, gum, and candy, alongside other food products. While detailed fiscal year 2025 segment and geographical breakdowns are not readily available in the provided data, the company’s global footprint ensures broad market penetration. Its significant presence across Latin America, North America, Asia, the Middle East, Africa, and Europe provides both revenue stability and opportunities for growth in developing markets, contributing to the overall strength of MDLZ stock. This geographical spread helps mitigate regional economic risks and capitalizes on diverse consumer preferences.
The competitive moat for MDLZ stock appears to be strengthening, as evidenced by a healthy revenue growth of 5.8% year-over-year. This growth indicates effective market strategies and continued demand for its products, even in a challenging economic climate. While a specific transcript quote highlighting the moat trend is not available, the consistent performance suggests management is successfully executing on initiatives to reinforce brand loyalty and expand product offerings. Investors looking at MDLZ valuation should consider this consistent growth as a positive sign for the company’s long-term sustainability.
When evaluating MDLZ stock against its peers in the Consumer Defensive sector, such as Coca-Cola Europacific Partners (CCEP), Colgate-Palmolive (CL), and Diageo (DEO), several distinctions emerge. While all operate in stable consumer staples, Mondelez’s focus on snacks differentiates it. Its strong brand portfolio, like Oreo and Cadbury, provides a robust consumer connection. Comparing MDLZ valuation metrics and growth rates against these peers can offer valuable insights into its relative attractiveness within the sector.
Mondelez International, Inc. analyst rating
Based on 41 analysts. 75.6% rate MDLZ Buy or Strong Buy.
Buy75.6%
Hold19.5%
Sell4.9%
A 75.6% “Buy” rating for MDLZ stock among 41 analysts is considered quite strong for the Consumer Defensive sector, which often sees a higher proportion of “Hold” ratings due to its stable, mature nature. This robust sentiment suggests a general confidence in Mondelez International’s future performance and its ability to deliver consistent returns for shareholders.
MDLZ financial scorecard
Comprehensive ranking of MDLZ across four financial dimensions.
5.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| Debt / equity | 0.84x | Moderate |
| Current ratio | 0.54x | Tight |
| FCF yield | 3.27% | Fair |
| DCF vs price | +113.7% | Undervalued |
| FMP debt score | 1/5 | Below avg |
6/10
| Metric | Value | Signal & strength |
|---|---|---|
| Gross margin | 28.77% | Low |
| Net margin | 6.65% | Low |
| EBITDA margin | 12.18% | Low |
| ROE | N/A | Low |
| ROA | N/A | Low |
| FMP ROE score | 3/5 | Average |
6.3/10
| Metric | Value | Signal & strength |
|---|---|---|
| Revenue growth YoY | +5.8% | Steady |
| Revenue (TTM) | $38.54B | Large scale |
| Forward EPS est. | $4.25721 | Analyst consensus |
| Forward revenue | $44.7B | Analyst consensus |
| FMP DCF score | 4/5 | Above avg |
4.0/10
| Metric | Value | Signal & strength |
|---|---|---|
| P/E ratio | 30.25x | Expensive |
| P/B ratio | 3.07x | Fair |
| P/S ratio | 2.0x | Cheap |
| DCF fair value | $131.05 | Undervalued |
| FMP P/E score | 2/5 | Below avg |
| FMP overall | 3/5 | Average |
Is MDLZ undervalued or overvalued?
vs 20x sector
Fair
Cheap
Undervalued
Fair
+9.2% upside
Assessing MDLZ valuation reveals a mixed picture. The P/E ratio stands at 30.25x, which is notably higher than the Food Confectioners sector average of 20x, indicating that the market might be pricing in future growth or a premium for its brand strength. This elevated P/E suggests that MDLZ stock is currently trading at a premium compared to its industry counterparts, requiring investors to consider whether its growth prospects justify this higher valuation.
Conversely, our discounted cash flow (DCF) model points to a fair value of $131.05, suggesting MDLZ is significantly undervalued by 113.7% against its current price. This discrepancy between the market’s P/E valuation and the intrinsic value derived from the DCF model presents a compelling case for investors seeking long-term value. Furthermore, the P/S ratio of 2.0x appears relatively cheap, while the P/B ratio of 3.07x is considered fair, providing additional perspectives on the MDLZ valuation landscape.
MDLZ financial health & key metrics
| Metric | MDLZ | Sector avg | Signal |
|---|---|---|---|
| P/E ratio | 30.25x | 20x | Expensive |
| Net margin | 6.65% | — | Fair |
| ROE / ROIC | N/A | — | N/A |
| Debt / equity | 0.84x | — | Moderate |
| FCF yield | 3.27% | — | Fair |
| Revenue growth | 5.8% | — | Steady |
| DCF fair value | $131.05 | — | Undervalued |
For value investors, the MDLZ stock presents an intriguing paradox. While the P/E ratio of 30.25x suggests a premium compared to the sector average of 20x, implying it might be an expensive entry point, the intrinsic value derived from a DCF model at $131.05 signals it is deeply undervalued by 113.7%. The company maintains a fair net margin of 6.65% and a steady revenue growth of 5.8%, backed by a moderate debt-to-equity ratio of 0.84x. The current ratio of 0.54x is tight, warranting attention, but a fair FCF yield of 3.27% provides some reassurance. Investors interested in MDLZ valuation should weigh the market’s current premium against its strong underlying business and significant intrinsic value potential.
Mondelez International, Inc. earnings history & next report
Mondelez International, Inc. reported EPS of $0.67, beating estimates by 10.2%. Next earnings: 2026-07-28 with EPS estimate of $0.69.
For the upcoming earnings report on 2026-07-28, investors will be keenly watching several key indicators. Beyond the expected EPS of $0.69, attention will be on organic revenue growth, particularly in key product categories and emerging markets, to gauge the underlying strength of the MDLZ stock business. Management commentary on commodity costs, pricing strategies, and supply chain resilience will also be crucial, as these factors directly impact profitability and future outlook in the Food Confectioners sector.
MDLZ daily short volume
Short volume data from FINRA CNMS Consolidated — shares sold short in the most recent US trading session. A high short ratio can signal bearish conviction or a potential short squeeze. Updated every trading day.
| Metric | Value | Context |
|---|---|---|
| Short volume ratio | 58.0% | 40-60% = moderate |
| Shares sold short | 1.11M | FINRA-reported for 2026-05-06 |
| Total reported volume | 1.91M | All FINRA ATS + OTC volume |
| Exempt short volume | 13.6K | Market-maker / arbitrage exempt trades |
| Signal | Moderate short activity | FINRA CNMS Consolidated |
MDLZ insider trading activity
Corporate insiders must report trades to the SEC within two business days.
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-04-30 | Stevens Brian | Officer: Svp, Ctr & Chief Accoun Off | Purchase | 20 | N/A | $0 | SEC |
| 2026-04-30 | Stevens Brian | Officer: Svp, Ctr & Chief Accoun Off | Sale | 63 | $61.46 | $3,872 | SEC |
| 2026-04-30 | Stevens Brian | Officer: Svp, Ctr & Chief Accoun Off | Sale | 20 | N/A | $0 | SEC |
| 2026-05-01 | Stevens Brian | Officer: Svp, Ctr & Chief Accoun Off | Sale | 1 | $61.55 | $62 | SEC |
| 2026-04-01 | Lilak Stephanie | Officer: Evp And Chief People Officer | Sale | 3,218 | $57.07 | $183,651 | SEC |
| 2026-04-01 | Kuhn Volker | Officer: Evp And President, Europe | Sale | 90 | $57.07 | $5,136 | SEC |
Source: SEC Form 4 via EDGAR · Data: Financial Modeling Prep · Not investment advice
Recent MDLZ analyst rating changes
| Firm | Previous | New rating | Date | Action | |
|---|---|---|---|---|---|
| TD Cowen | Buy | → | Buy | 2026-04-29 | Reiterated |
| UBS | Neutral | → | Neutral | 2026-04-29 | Reiterated |
| JP Morgan | Overweight | → | Overweight | 2026-04-29 | Reiterated |
| Evercore ISI Group | Outperform | → | Outperform | 2026-04-29 | Reiterated |
| Barclays | Overweight | → | Overweight | 2026-04-29 | Reiterated |
Mondelez International, Inc. stock news today
No major news for Mondelez International, Inc. (MDLZ) stock reported this week.
How does MDLZ compare to its peers?
Within the Consumer Defensive sector, Mondelez International (MDLZ) stands as a prominent player, but understanding its competitive landscape requires examining its peers. Investors considering MDLZ stock might also evaluate other companies that offer similar defensive characteristics and potential for stable returns.
Coca-Cola Europacific Partners (CCEP) is a leading bottler and distributor of Coca-Cola products across Western Europe, Australia, and New Zealand. It offers exposure to the beverage segment of consumer defensive, distinct from MDLZ’s snack focus.
Colgate-Palmolive (CL) is a global consumer products company focused on oral care, personal care, home care, and pet nutrition. Its strong household brand presence provides a different consumer staple angle compared to Mondelez’s confectionery and biscuit dominance.
Diageo (DEO) is a multinational alcoholic beverages company with a portfolio of premium spirits and beers. Investing in Diageo provides exposure to the resilient alcoholic beverage market, offering another avenue within the consumer defensive sector for comparison with MDLZ stock.
Alert Invest · Free Newsletter
Get alerts when top investors buy a stock!
Track when institutional investors, insiders, and analysts change their positions. Alert Invest sends you a data-driven brief the moment it happens — free, every week.
- Institutional & insider moves
- Analyst upgrades & downgrades
- 100% free — unsubscribe anytime
FAQ — Mondelez International, Inc. (MDLZ) stock
For informational purposes only. Not investment advice. Data: Financial Modeling Prep & SEC EDGAR. Always do your own research.
